Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) FCF Margin (2022 - 2026)

Envoy Medical's FCF Margin history spans 5 years, with the latest figure at 15541.03% for Q1 2026.

  • On a quarterly basis, FCF Margin fell 743016.0% to 15541.03% in Q1 2026 year-over-year; TTM through Mar 2026 was 8850.43%, a 84948.0% decrease, with the full-year FY2025 number at 7626.56%, up 78633.0% from a year prior.
  • FCF Margin hit 15541.03% in Q1 2026 for Envoy Medical, down from 7809.33% in the prior quarter.
  • Over the last five years, FCF Margin for COCH hit a ceiling of 1296.25% in Q3 2023 and a floor of 15541.03% in Q1 2026.
  • Historically, FCF Margin has averaged 8271.8% across 5 years, with a median of 8110.87% in 2025.
  • Biggest five-year swings in FCF Margin: surged 1051222bps in 2023 and later plummeted -804625bps in 2024.
  • Tracing COCH's FCF Margin over 5 years: stood at 12100.0% in 2022, then grew by 3bps to 11753.68% in 2023, then grew by 8bps to 10850.0% in 2024, then increased by 28bps to 7809.33% in 2025, then tumbled by -99bps to 15541.03% in 2026.
  • Business Quant data shows FCF Margin for COCH at 15541.03% in Q1 2026, 7809.33% in Q4 2025, and 10311.9% in Q3 2025.